S1 E13 The Weekly Dose Podcast 4/16/24
This week Dave Knapp covers GLP-1 censorship on TikTok, the rise of bootleg medication scrutiny, and just how big the GLP-1 market may get in 2024.
Email Alerts: https://www.onthepen.com/emails
BECOME A MEMBER HERE TO WATCH THE VIDEO:
https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join
Bloomberg #ReleaseTheVials Feature:
https://www.bloomberg.com/news/articles/2024-04-02/zepbound-shortage-patients-push-eli-lilly-to-release-more-obesity-drug-supply
Yahoo Finanace #ReleaseTheVials Feature VIDEO: https://youtu.be/nQbYa47DF4Q?feature=shared
#mounjaro #zepbound #tirzepatide
Bootleg Meds:
https://www.reuters.com/business/healthcare-pharmaceuticals/more-than-250-websites-selling-fake-weight-loss-drugs-reported-by-anti-2024-04-15/
Drug Shortage Reporting: https://www.wsj.com/health/healthcare/drug-medication-shortages-us-olympic-amoxicillin-107fa9d8
GLP-1 Sales:
https://www.fiercepharma.com/marketing/glp-1s-track-take-drug-sales-crown-pd-1-inhibitors-2024-analyst
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!